BarnaM., UomoI. and PastorelloM. (2013) “Oral Agents for Treatment of Patients with Advanced Pancreatic Neuroendocrine Tumors: Could Pharmaeconomic, Cost-Effectiveness Data Play a Significant Role?”, JOP. Journal of the Pancreas, 14(1), pp. 102-104. doi: 10.6092/1590-8577/1354.